Literature DB >> 11012765

Interleukin-8 fails to induce human immunodeficiency virus-1 expression in chronically infected promonocytic U1 cells but differentially modulates induction by proinflammatory cytokines.

C T Tiemessen1, B Kilroe, D J Martin.   

Abstract

This study addresses the role of interleukin (IL)-8, a CXC-chemokine, the level of which is reported to be raised in the peripheral circulation of human immunodeficiency virus-1 (HIV-1)-infected individuals, during the induction of HIV-1 expression from latency and during cytokine-mediated HIV-1 up-regulation. IL-8 at the higher concentrations tested (> or = 100 ng/ml) was unable to induce HIV-1 expression in the chronically infected promonocytic U1 cell line, as measured by p24 antigen enzyme-linked immunosorbent assay (ELISA), whereas at lower concentrations of 1 and 10 ng/ml, constitutive HIV-1 expression was only marginally reduced. HIV-1 replication in acutely infected U937 cells was also significantly reduced by IL-8. The potent up-regulation of HIV-1 expression in U1 cells by tumour necrosis factor-alpha (TNF-alpha) remained unaffected by the addition of IL-8. HIV-1 induction by IL-1beta, IL-6 and TNF-beta, cytokines grouped here as intermediate HIV-1 inducers, was suppressed by IL-8 at concentrations of 1 and 10 ng/ml. However, IL-8 at 100 ng/ml did not significantly alter the effect of IL-1beta, synergized with IL-6 in enhancing, and marginally suppressed TNF-beta-induced HIV-1 expression. IL-8 suppressed granulocyte-macrophage colony-stimulating factor (GM-CSF) and enhanced interferon-gamma (IFN-gamma)-induced HIV-1 expression in a dose-dependent manner. Pretreatment of U1 cells with IL-8 did not alter the IL-8-mediated effects on cytokine-induced HIV-1 expression, suggesting that this chemokine exerts its effect at the time of HIV-1 induction or at a postinduction stage. Furthermore, IL-8 was itself induced by cytokines that up-regulate HIV-1 expression in U1 cells and the levels produced correlated directly with the levels of p24 antigen produced, suggesting common pathways for cytokine induction of both HIV-1 and IL-8. These results show that IL-8, typically a non-inducer, can differentially modulate HIV-1 expression in U1 cells and that this is dependent on the inducing cytokine and on the concentration of IL-8.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11012765      PMCID: PMC2327060          DOI: 10.1046/j.1365-2567.2000.00100.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  Impaired interleukin-8-induced degranulation of polymorphonuclear neutrophils from human immunodeficiency virus type 1-infected individuals.

Authors:  S Meddows-Taylor; D J Martin; C T Tiemessen
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Interleukin-4 regulation of cytokine-induced HIV1 and interleukin-8 expression in promonocytic U1 cells is concentration- and cytokine-dependent.

Authors:  C T Tiemessen; B Kilroe; D J Martin
Journal:  Res Virol       Date:  1998 Jan-Feb

3.  A new class of membrane-bound chemokine with a CX3C motif.

Authors:  J F Bazan; K B Bacon; G Hardiman; W Wang; K Soo; D Rossi; D R Greaves; A Zlotnik; T J Schall
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

4.  Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation.

Authors:  Y Pan; C Lloyd; H Zhou; S Dolich; J Deeds; J A Gonzalo; J Vath; M Gosselin; J Ma; B Dussault; E Woolf; G Alperin; J Culpepper; J C Gutierrez-Ramos; D Gearing
Journal:  Nature       Date:  1997-06-05       Impact factor: 49.962

5.  Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

Authors:  T M Folks; J Justement; A Kinter; C A Dinarello; A S Fauci
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

6.  Reduced expression of interleukin-8 receptors A and B on polymorphonuclear neutrophils from persons with human immunodeficiency virus type 1 disease and pulmonary tuberculosis.

Authors:  S Meddows-Taylor; D J Martin; C T Tiemessen
Journal:  J Infect Dis       Date:  1998-04       Impact factor: 5.226

7.  Dysregulated production of interleukin-8 in individuals infected with human immunodeficiency virus type 1 and Mycobacterium tuberculosis.

Authors:  S Meddows-Taylor; D J Martin; C T Tiemessen
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

8.  Interleukin-10-induced HIV-1 expression is mediated by induction of both membrane-bound tumour necrosis factor (TNF)-alpha and TNF receptor type 1 in a promonocytic cell line.

Authors:  W Barcellini; G P Rizzardi; J B Marriott; C Fain; R J Shattock; P L Meroni; G Poli; A G Dalgleish
Journal:  AIDS       Date:  1996-07       Impact factor: 4.177

9.  Leukotriene B4 and interleukin-8 in human immunodeficiency virus-related pulmonary disease.

Authors:  G Y Lipschik; M E Doerfler; J A Kovacs; W D Travis; V A Andrawis; M G Lawrence; J R Dichter; F P Ognibene; J H Shelhamer
Journal:  Chest       Date:  1993-09       Impact factor: 9.410

10.  Release of polymorphonuclear leukocytes from the bone marrow by interleukin-8.

Authors:  T Terashima; D English; J C Hogg; S F van Eeden
Journal:  Blood       Date:  1998-08-01       Impact factor: 22.113

View more
  4 in total

1.  Attenuated Listeria monocytogenes vectors overcome suppressive plasma factors during HIV infection to stimulate myeloid dendritic cells to promote adaptive immunity and reactivation of latent virus.

Authors:  Elizabeth A Miller; Meredith R Spadaccia; Thomas Norton; Morgan Demmler; Ramya Gopal; Meagan O'Brien; Nathaniel Landau; Thomas W Dubensky; Peter Lauer; Dirk G Brockstedt; Nina Bhardwaj
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

2.  Interactions among human immunodeficiency virus (HIV)-1, interferon-gamma and receptor of activated NF-kappa B ligand (RANKL): implications for HIV pathogenesis.

Authors:  J M Fakruddin; J Laurence
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

Review 3.  Oral infectious diseases: a potential risk factor for HIV virus recrudescence?

Authors:  O A González; J L Ebersole; C B Huang
Journal:  Oral Dis       Date:  2009-04-02       Impact factor: 3.511

4.  Entry of Polarized Effector Cells into Quiescence Forces HIV Latency.

Authors:  Curtis Dobrowolski; Saba Valadkhan; Amy C Graham; Meenakshi Shukla; Angela Ciuffi; Amalio Telenti; Jonathan Karn
Journal:  mBio       Date:  2019-03-26       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.